학술논문
LBA49 mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1288-S1289
Subject
Language
ISSN
0923-7534